You have 9 free searches left this month | for more free features.

City

Atlanta (1)

Baltimore (1)

New York (1)

North Haven (1)

Sacramento (1)

Condition

Advanced Non-small Cell Lung Cancer (1)

Non-small Cell Lung Cancer (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Phase

phase 1 (2)

Sponsor

Jiesi Yingda Pharmaceutical Technology (Suzhou) Co., Ltd. (1)

Vitrac Therapeutics, LLC (1)

Collaborator

Westat (1)

Intervention

vic-1911 (2)

osimertinib mesylate tablets (1)

sotorasib (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

vic-1911

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

NSCLC Trial in United States (VIC-1911, sotorasib)

Recruiting

Non-small Cell Lung Cancer

VIC-1911
sotorasib

Sacramento, California
+4 more

Jan 5, 2023

Advanced NSCLC Trial (VIC-1911, Osimertinib Mesylate Tablets)

Not yet recruiting

Advanced Non-small Cell Lung Cancer

VIC-1911
Osimertinib Mesylate Tablets

(no location specified)

Aug 3, 2022